Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tykundegex]

I speculate that management are not in any rush to partner or sell, as they know what they have and would be smart to maximize its value. What's an extra 6-12 months for double the valuation?

The excellent trial results, the forthcoming (and certainly to be approved) NDA, and the market study, all point to a very high probability that KIT-302 will generate peak sales of over $1bn. I therefore 'hope' for a $1bn MC. I realize that's improbable, but it's not inconceivable